![](/img/cover-not-exists.png)
Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors
Yoshiba, Satoshi, Jansen, Mendel, Matsushima, Nobuko, Chen, Shuquan, Mendell, JeanneVolume:
77
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3011-0
Date:
May, 2016
File:
PDF, 1.27 MB
english, 2016